Clinical benefits of diagnosing incipient AA amyloidosis in pediatric rheumatic diseases as estimated from a retrospective study

References

• Strauss R G, Schubert W K, McAdams A J. Amy-loidosis in childhood. J Pediatr. 1969; 74: 272–282
   PubMed Web of Science ®Google Scholar
• Trainin E B, Spitzer A, Greifer I. Amyloidosis in juvcnile rheumatoid arthritis. New York State Journal of Medicine 1978; 1: 72–77
   Google Scholar
• Ludomirsky A, Passwcll J, Boichis H. Amyloidosis in childrcn with familial Mediterranean fever. Arch Dis Child. 1981; 56: 464–467
   Google Scholar
• Zemer D, Livneh A, Danon Y, Pras M, Sohar E. Long-term colchicine treatment in children nith familial Mediterranean fever. Arthritis Rheum 1991; 34: 973–977
   PubMed Web of Science ®Google Scholar
• Woo P. Amyloidosis in children. Baillière's clin Rheumatol 1994; 8: 691–697
   Google Scholar
• Ben-Chetrit E, Levy M. Colchicine prophylaxis in familial Mediterranean fever: Reappraisal after 15 years. Sem. Arthritis Rheum 1991; 20: 241–246
   PubMed Web of Science ®Google Scholar
• Schnitzer T J, Ansell B M. Amyloidosis in jubenile chronic polyarthritis. Arthritis Rheum. 1977; 20(Suppl.)245–252
   Google Scholar
• David J, Vouyiouka O, Ansell B M, Hall A, Woo P. Amyloidosis in juvenile chronic arthritis: A morbidity and mortality study. Clin Exp Rheumatol. 1993; 11: 85–90
   PubMed Web of Science ®Google Scholar
• Lévy M, Prieur A M, Gubler M, Hayem F, Manigne P, Cheron G, Niaudet P. Renal involvement in juvenile chronic arthritis: Clinical and pathologic features. Am J Kidney Dis. 1987; 9: 138–146
   Google Scholar
• Schuchmann L, Michels H, Renaud M, Renz K. Die Amyloidose - eine gefurchtete Folgekrankheit der juvenilen chronischen Arthritis (JCA). Klinisclie Pädiatrie. 1981; 193: 67–72
   Google Scholar
• Hankins P N, Richardson S, Vigushin D M, David J, Kelsey C R, Gray K ES, Hall M A, Woo P, Lavender J P, Pepys M B. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in junenile rheumatoid arthritis. Arthritis Rheum 1993; 36: 8–12; 851
   Google Scholar
• Linke R P, Gärlner H-V, Michels H. High sensitivity diagnosis of amyloidosis using Congo red and inimunohistochemistry detects missed amyloid deposits. J Histochem Cytochem. 1995; 43: 863–869
   PubMed Web of Science ®Google Scholar
• Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem. 1962; 10: 355–364
   Web of Science ®Google Scholar
• Sternberger L A. Immunohistochemistry. Wiley, New York 1979
   Google Scholar
• Michels H, Linke R P. Subcutaneous fat biopsy-suitable as a screening inkestigation for AA amyloidosis in childhood?. Rev Esp Reumatol. 1993; 20: 368
   Google Scholar
• Falck H M, Törnroth T., Skrifvars B, Wepelius O. Resolution of renal amlloidosis secondary to rheumatoid arthritis. Acta Med Scand. 1979; 205: 651–656
   Google Scholar
• Cusano A J, Bland J H, Lapenas D J, Cohen A S, Libbey C. Juvenile rheumatoid arthritis with renal amyloidosis: A 23-year survival. J Rheumatol 1982; 9: 921–925
   Google Scholar
• Perez-Villa F, Campistol J M, Ferrando J, Rotet A. Renal amyloidosis secondary to acne conglobata. Int J Dermatol 1989; 28: 132–133
   PubMed Web of Science ®Google Scholar
• Escalarite A, Chrcsniann G R, Quismorio F P, Jr. Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine. Arthritis Rheum. 1991; 34: 920–922
   Google Scholar
• Gertz M A, Kyle R A. Amyloidosis: prognosis and treatment. Sem Arthritis Rheum. 1994; 24: 124–138
   PubMed Web of Science ®Google Scholar
• Michels H, Linke R P. Development of amyloidosis as an unrecognized side effect of gold therapy: comment on the article by, Shapiro and Spicra. Arthritis Rheum. 1996; 39: 1932–1933
   PubMedGoogle Scholar
• Michels H, Donini U, Linke R P. Resolution of AA amyloidosis in juvenile rheumatoid arthritis (JRA) as shown with computer-aided quantitation of amyloid. Amyloid and Amyloidosis 1993, R Kisilevsky, M Renson, B Frangionc, J Ciauldic, T Mucklc, I Young. The Parthenon Publishing Group Ltd., Casterton Hall 1991; 694–696
   Google Scholar
• McSneeney P A, Nash R A, Storb R, Furst D E, Gauthier J, Sullivan K M. Autologous stem ccll transplantation for autoimmune diseases: issues in protocol decelopment. J Rheumatol. 1997; 24(Supp1.48)79–84
   Google Scholar
• Martini A, Maccario R, Ravelli A, Montagna D, De Renedetti F, Bonetti F, Viola S, Zecca M, De Stefano P, Locatelli F. Marked and sustained improvement one year after autologous peripheral blood stem cell transplant in a girl lvith severe progressibe systemic sclerosis. Rev Rhum [Engl Ed] 1997; 64(Suppl.)248S, (Abstract)
   Google Scholar
• Messner R P. rhc potential or bone marron stem cell transplantation in the treatment of autoirnniune diseases. J Rheumatol. 1997; 24: 819–821
   Google Scholar
• Savolainen H A, Isomäki H A. Dccreasc in the nuinber of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis. J Rheumatol. 1993; 20: 1201–1203
   PubMed Web of Science ®Google Scholar